SHSE:688336's Quick Ratio is ranked better than 93.19% of 1410
companies
in the Biotechnology industry
Industry Median: 3.6
vs SHSE:688336: 20.98
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Sunshine Guojian Pharmaceutical (Shanghai) Co Quick Ratio Related Terms
Sunshine Guojian Pharmaceutical (Shanghai) Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Guojian Pharmaceutical (Shanghai) Co Quick Ratio Chart
Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Guojian Pharmaceutical (Shanghai) Co Quick Ratio vs Biotechnology Industry
Sunshine Guojian Pharmaceutical (Shanghai) Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) has a Quick Ratio of 20.98 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. This is 126% above median its historical median of 9.30. Over the past decade, Sunshine Guojian Pharmaceutical (Shanghai) Co's Quick Ratio has ranged from 1.97 to 20.98. According to the industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #96 out of 1410 companies in the Biotechnology industry, placing it in the top 6.8%.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co's Quick Ratio too high?
Sunshine Guojian Pharmaceutical (Shanghai) Co's current Quick Ratio of 20.98 is 126% above median its 10-year median of 9.30. Over the past 10 years, this metric has ranged from a low of 1.97 to a high of 20.98. The Biotechnology industry median Quick Ratio is 3.60. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 20.98 is 482.8% above this industry median. Based on the distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #96 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunshine Guojian Pharmaceutical (Shanghai) Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunshine Guojian Pharmaceutical (Shanghai) Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunshine Guojian Pharmaceutical (Shanghai) Co ranks #96 out of 1410 companies for Quick Ratio. This places Sunshine Guojian Pharmaceutical (Shanghai) Co in the top 7% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.60. Sunshine Guojian Pharmaceutical (Shanghai) Co's value of 20.98 is 482.8% above this benchmark. Historically, Sunshine Guojian Pharmaceutical (Shanghai) Co's own Quick Ratio has ranged from 1.97 to 20.98 over the past decade. While the company's 10-year median is 9.30 vs. the industry median of 3.60, Sunshine Guojian Pharmaceutical (Shanghai) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Quick Ratio of 20.98 is 482.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Sunshine Guojian Pharmaceutical (Shanghai) Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Guojian Pharmaceutical (Shanghai) Co's current Quick Ratio is 20.98, which is 126% above median its own 10-year median of 9.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) is currently considered Fairly Valued. The stock's GF Value™ is ¥66.79, compared to a current price of ¥60.72 — trading 9.1% below its estimated fair value. The current Quick Ratio is 20.98, which is 126% above median its 10-year median of 9.30 and 482.8% above the Biotechnology industry median of 3.60. Sunshine Guojian Pharmaceutical (Shanghai) Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336), the current Quick Ratio is 20.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Overvalued in 2026?
Based on GuruFocus' analysis, Sunshine Guojian Pharmaceutical (Shanghai) Co stock appears to be undervalued.
The current stock price of ¥60.72 is trading 9.1% below its estimated GF Value™ of ¥66.79.
GuruFocus considers Sunshine Guojian Pharmaceutical (Shanghai) Co to be Fairly Valued.
Key valuation signals for SHSE:688336:
Quick Ratio: 20.98 (126% above median its 10-year median of 9.30)
GF Value™: ¥66.79 vs. price of ¥60.72 (9.1% below fair value)
Industry Position: 482.8% above the Biotechnology median (#96 of 1410)
No single metric tells the full story. See the SHSE:688336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
81GF Score
Get the complete analysis for SHSE:688336
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688336 has been successfully added to your 
